Fremanezumab Treatment of Migraine in Women With Menstrual Migraine Ages 18-45
Clinical trial NCT06173661 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06173661
- Sponsor
- Brigham and Women's Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-01
- Primary completion
- 2026-07-01
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.